Alumis Inc share price logo

Alumis Inc Share Price

NASDAQ: ALMS

Mid Cap

$23.07

-0.29

(-1.24%)

as on

Alumis Inc Stock Performance

as on March 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $22.08
    $23.30
    downward going graph

    4.29%

    Downside

    1.00%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.76
    $30.60
    downward going graph

    88.04%

    Downside

    32.64%

    Upside

    downward going graph

Alumis Inc share price movements today

Previous Close
$23.36
Open
$22.96
Volume
939.4K
Day's Low - High
$22.08 - $23.30
52 Week Low - High
$2.76 - $30.60

Alumis Inc Historical Returns

1 Month Return
-20.52 %
3 Month Return
+ 104.91 %
1 Year Return
+ 484 %
3 Year Return
0 %
5 Year Return
0 %

Alumis Inc Stock Fundamentals & Key Indicators

Check Alumis Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.2B

EPS (TTM)

-3.1267

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-86.68%

Alumis Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alumis Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Alumis Inc image
Alumis Inc
NA$3.2BNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B126.75%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.49%29.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B58.91%17.6731.41%

Stock Returns calculator for Alumis Inc Stock including INR - Dollar returns

The Alumis Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Alumis Inc investment value today

Current value as on today

₹5,86,291

Returns

₹4,86,291

(+486.29%)

Returns from Alumis Inc Stock

₹4,76,750 (+476.75%)

Dollar Returns*

₹9,541 (+9.54%)

Alumis Inc Stock’s Investor Sentiment and Interest

Search interest for Alumis Inc Stock has decreased by -59% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-59% versus previous 30 day period

Alumis Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
3
17
2
2
1
Gross Profit
0
0
0
0
0
0
17
2
2
1
Operating Income
-43
-40
-47
-56
-98
-98
-101
-140
-115
-84
EBITDA
-43
-39
-46
-55
-97
-93
-100
-119
-109
-83
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
-
-
0
-
Income Before Tax
-43
-39
-49
-56
-93
-94
-98
50
-110
-92
Income Tax Expense
-
-
-
-
-
-
-
-8
-
-
Net Income
-43
-39
-49
-56
-93
-94
-98
59
-110
-92
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-3121.18%
-569.11%
2225.09%
-5360.70%
-4817.57%

Alumis Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
24
Gross Profit
0
-1
-3
20
Operating Income
-113
-158
-300
-427
EBITDA
-113
-156
-297
-453
Interest Expense
-
-
-
-
Depreciation
0
1
3
-
Income Before Tax
-111
-154
-294
-251
Income Tax Expense
-
-
-
-8
Net Income
-111
-154
-294
-243
Net Profit Margin
0.00%
0.00%
0.00%
-1011.75%

Alumis Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-39
-49
-56
-93
-94
-98
59
-110
-92
Operating Cash Flow
-33
-44
-52
-83
-74
-80
-106
-110
-71
Investing Cash Flow
-4
-18
-32
-93
30
39
129
24
95
Financing Cash Flow
29
129
128
235
0
-
0
-
1
Change in Cash
-8
66
43
58
-43
-40
23
-86
24

Alumis Inc Annual Cash Flow

All numbers in Millions USD

Dec 2023
Dec 2024
Dec 2025
Net Income
-154
-294
-243
Operating Cash Flow
-129
-255
-369
Investing Cash Flow
60
-113
287
Financing Cash Flow
89
492
2
Change in Cash
20
123
-79

Alumis Inc News & Key Events

  • img

    Today's Timeline - 06 January

    Tue, 09:17 PM

    -

    Alumis reports successful Phase 3 trial results for envudeucitinib, leading to a 115.58% stock increase.

Insights on Alumis Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ALMS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, ALMS stock has moved up by 485.5%

About Alumis Inc

Alumis Inc. is a late-stage biopharmaceutical company. The Company is engaged in developing next-generation targeted therapies with the potential to significantly improve patient health and outcomes across a range of immune-mediated diseases. Leveraging its proprietary data analytics platform and precision approach, the Company is developing a pipeline of oral tyrosine kinase 2 (TYK2) inhibitors, consisting of ESK-001 for the treatment of systemic immune-mediated disorders, such as moderate-to-severe plaque psoriasis and systemic lupus erythematosus, and A-005 for the treatment of neuroinflammatory and neurodegenerative diseases such as multiple sclerosis and Parkinson’s Disease. In addition, its pipeline also includes lonigutamab, a subcutaneously delivered anti-insulin-like growth factor 1 receptor therapy for the treatment of thyroid eye disease, as well as several preclinical programs identified through this precision approach.
OrganisationAlumis Inc
Headquarters280 East Grand Avenue, South San Francisco, CA, United States, 94080
CEOMr. Martin Babler Ph.D.
E-voting on sharesClick here to vote

Key Management of Alumis Inc

Name

Title

Dr. David M. Goldstein Ph.D.

Chief Scientific Officer

Mr. John R. Schroer C.F.A.

Chief Financial Officer

Ms. Sanam Pangali J.D.

Chief Legal Officer & Corporate Secretary

Mr. Mark Bradley

Chief Development Officer

Mr. Kolbot By Ph.D.

Senior VP & Head of Technical Operations

Ms. Grace Halteh

Senior VP & Head of Quality and Regulatory

Mr. Jack Danilkowicz

Chief Commercial Officer

Mr. Martin Babler Ph.D.

President, CEO & Chairman

FAQs

What is Alumis Inc share price today?

Alumis Inc share price today is $23.07 as on at the close of the market. Alumis Inc share today touched a day high of $23.3 and a low of $22.08.

What is the 52 week high and 52 week low for Alumis Inc share?

Alumis Inc share touched a 52 week high of $30.6 on and a 52 week low of $2.76 on . Alumis Inc stock price today i.e. is closed at $23.07,which is 24.61% down from its 52 week high and 735.84% up from its 52 week low.

What is Alumis Inc's market capitalisation today?

Alumis Inc market capitalisation is $0.00T as on .

How to invest in Alumis Inc Stock (ALMS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alumis Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alumis Inc Shares that will get you 0.0650 shares as per Alumis Inc share price of $23.07 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Alumis Inc Stock (ALMS) from India?

Indian investors can start investing in Alumis Inc (ALMS) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Alumis Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Alumis Inc share’s latest price of $23.07 as on March 25, 2026 at 1:29 am IST, you will get 0.4335 shares of Alumis Inc. Learn more about fractional shares .